COVID-19 outbreaks in acute and long-term care: Conceptualizing patterns of vulnerability and benefits of interventions

Melissa K. Andrew; Shelly A. McNeil

doi:10.1016/j.lanepe.2022.100312

COVID-19 outbreaks in acute and long-term care: Conceptualizing patterns of vulnerability and benefits of interventions

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	100312
Journal	The Lancet Regional Health - Europe
Volume	14
DOIs	https://doi.org/10.1016/j.lanepe.2022.100312
Publication status	Published - Mar 2022

ASJC Scopus Subject Areas

Health Policy
Oncology
Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.lanepe.2022.100312

Cite this

@article{4deb7c5c42e54389801e26ca001e8126,

title = "COVID-19 outbreaks in acute and long-term care: Conceptualizing patterns of vulnerability and benefits of interventions",

author = "Andrew, {Melissa K.} and McNeil, {Shelly A.}",

note = "Funding Information: MKA reports grants from the Canadian Frailty Network, CIHR, Public Health Agency of Canada, Sanofi, Pfizer, Merck and GSK, and payments from Pfizer, Sanofi and Seqirus outside the submitted work. SAM reports grants and payments from Pfizer, GSK, Merck, Novartis and Sanofi, outside the submitted work. ",

year = "2022",

month = mar,

doi = "10.1016/j.lanepe.2022.100312",

language = "English",

volume = "14",

journal = "The Lancet Regional Health - Europe",

issn = "2666-7762",

publisher = "Elsevier Ltd.",

}

TY - JOUR

T1 - COVID-19 outbreaks in acute and long-term care

T2 - Conceptualizing patterns of vulnerability and benefits of interventions

AU - Andrew, Melissa K.

AU - McNeil, Shelly A.

N1 - Funding Information: MKA reports grants from the Canadian Frailty Network, CIHR, Public Health Agency of Canada, Sanofi, Pfizer, Merck and GSK, and payments from Pfizer, Sanofi and Seqirus outside the submitted work. SAM reports grants and payments from Pfizer, GSK, Merck, Novartis and Sanofi, outside the submitted work.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85123783332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123783332&partnerID=8YFLogxK

U2 - 10.1016/j.lanepe.2022.100312

DO - 10.1016/j.lanepe.2022.100312

M3 - Comment/debate

AN - SCOPUS:85123783332

SN - 2666-7762

VL - 14

JO - The Lancet Regional Health - Europe

JF - The Lancet Regional Health - Europe

M1 - 100312

ER -

COVID-19 outbreaks in acute and long-term care: Conceptualizing patterns of vulnerability and benefits of interventions

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this